Logo image of ALMAS.PA

MASTRAD (ALMAS.PA) Stock Fundamental Analysis

EPA:ALMAS - Euronext Paris - Matif - FR0004155687 - Common Stock - Currency: EUR

0.0224  0 (-6.67%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ALMAS. ALMAS was compared to 35 industry peers in the Household Durables industry. ALMAS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALMAS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALMAS had negative earnings in the past year.
ALMAS had a positive operating cash flow in the past year.
In the past 5 years ALMAS reported 4 times negative net income.
In the past 5 years ALMAS reported 4 times negative operating cash flow.
ALMAS.PA Yearly Net Income VS EBIT VS OCF VS FCFALMAS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M

1.2 Ratios

The Return On Assets of ALMAS (-17.05%) is worse than 94.29% of its industry peers.
ALMAS's Return On Equity of -36.33% is on the low side compared to the rest of the industry. ALMAS is outperformed by 88.57% of its industry peers.
Industry RankSector Rank
ROA -17.05%
ROE -36.33%
ROIC N/A
ROA(3y)-19.11%
ROA(5y)-15.69%
ROE(3y)-64.2%
ROE(5y)-64.51%
ROIC(3y)N/A
ROIC(5y)N/A
ALMAS.PA Yearly ROA, ROE, ROICALMAS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALMAS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALMAS.PA Yearly Profit, Operating, Gross MarginsALMAS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

4

2. Health

2.1 Basic Checks

ALMAS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALMAS has about the same amount of shares outstanding.
ALMAS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALMAS has an improved debt to assets ratio.
ALMAS.PA Yearly Shares OutstandingALMAS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ALMAS.PA Yearly Total Debt VS Total AssetsALMAS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

ALMAS has an Altman-Z score of 0.12. This is a bad value and indicates that ALMAS is not financially healthy and even has some risk of bankruptcy.
ALMAS has a worse Altman-Z score (0.12) than 94.29% of its industry peers.
ALMAS has a debt to FCF ratio of 4.35. This is a neutral value as ALMAS would need 4.35 years to pay back of all of its debts.
ALMAS's Debt to FCF ratio of 4.35 is fine compared to the rest of the industry. ALMAS outperforms 71.43% of its industry peers.
ALMAS has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
ALMAS has a Debt to Equity ratio (0.47) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.35
Altman-Z 0.12
ROIC/WACCN/A
WACC6%
ALMAS.PA Yearly LT Debt VS Equity VS FCFALMAS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

ALMAS has a Current Ratio of 1.56. This is a normal value and indicates that ALMAS is financially healthy and should not expect problems in meeting its short term obligations.
ALMAS's Current ratio of 1.56 is in line compared to the rest of the industry. ALMAS outperforms 45.71% of its industry peers.
ALMAS has a Quick Ratio of 1.39. This is a normal value and indicates that ALMAS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.39, ALMAS belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.39
ALMAS.PA Yearly Current Assets VS Current LiabilitesALMAS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.51% over the past year.
ALMAS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -69.48%.
Measured over the past years, ALMAS shows a very negative growth in Revenue. The Revenue has been decreasing by -18.76% on average per year.
EPS 1Y (TTM)44.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-208.33%
Revenue 1Y (TTM)-69.48%
Revenue growth 3Y-41.89%
Revenue growth 5Y-18.76%
Sales Q2Q%-90.5%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALMAS.PA Yearly Revenue VS EstimatesALMAS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ALMAS.PA Yearly EPS VS EstimatesALMAS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -0.1 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALMAS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALMAS.PA Price Earnings VS Forward Price EarningsALMAS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ALMAS is valued a bit cheaper than 80.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.28
EV/EBITDA N/A
ALMAS.PA Per share dataALMAS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALMAS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MASTRAD

EPA:ALMAS (3/7/2025, 7:00:00 PM)

0.0224

0 (-6.67%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners31.67%
Ins Owner ChangeN/A
Market Cap1.85M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.99
P/FCF 6.28
P/OCF 2.27
P/B 0.84
P/tB 1.17
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY15.92%
OCF(TTM)0.01
OCFY44.09%
SpS0.02
BVpS0.03
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.05%
ROE -36.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 15.77%
ROA(3y)-19.11%
ROA(5y)-15.69%
ROE(3y)-64.2%
ROE(5y)-64.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.35
Debt/EBITDA N/A
Cap/Depr 114.54%
Cap/Sales 27.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.39
Altman-Z 0.12
F-Score4
WACC6%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)14.92%
Cap/Sales(5y)13.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-208.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-69.48%
Revenue growth 3Y-41.89%
Revenue growth 5Y-18.76%
Sales Q2Q%-90.5%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y116.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y158.39%
OCF growth 3YN/A
OCF growth 5YN/A